Assignee
ASGARD THERAPEUTICS AB
SE·1 granted patent·4 pending applications·2 citations·filing 2018–2022
Top patents by PatentIndex Score
5 records- 0163US11345891B2Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereofASGARD THERAPEUTICS AB·Filed 2018·Granted May 31, 2022·2 cites·6 claims
- 0247US2022325244A1Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereofASGARD THERAPEUTICS AB·Filed 2022·Application pending·0 cites
- 0341US2025186489A1Reprogramming of cells to type 1 conventional dendritic cells or antigen-presenting cellsASGARD THERAPEUTICS AB·Filed 2022·Application pending·0 cites
- 0434US2024018200A1Compositions, constructs and vectors for cell reprogrammingASGARD THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0530US2024139239A1Compositions for reprogramming cells into dendritic cells type 2 competent for antigen presentation, methods and uses thereofASGARD THERAPEUTICS AB·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →